Half maximal effective concentration (EC50) is a measure of the concentration of a drug, antibody or toxicant which induces a biological response halfway...
9 KB (1,023 words) - 21:43, 27 August 2024
inversely related to its half maximal effective concentration (EC50) value. The EC50 can be measured for a given agonist by determining the concentration...
14 KB (1,622 words) - 03:21, 4 September 2024
IC50 is comparable to other measures of potency, such as EC50 for excitatory drugs. EC50 represents the dose or plasma concentration required for obtaining...
10 KB (1,084 words) - 20:25, 28 August 2024
potential channels TRPA1 (EC50 = 700 nM), TRPV1 (EC50 = 1,300 nM), TRPV2 (EC50 = 1,720 nM), TRPV3 (EC50 = 1,000 nM), and TRPV4 (EC50 = 5,100 nM) (efficacy...
24 KB (1,932 words) - 19:17, 22 September 2024
receptor agonist (Ki > 5 μM; EC50 > 5 μM) Farnesoid X receptor antagonist (IC50 = 5–50 μM) Pregnane X receptor agonist (EC50 = 2.4 μM ((Z)-isomer)) Guggulsterone...
7 KB (505 words) - 18:43, 20 October 2024
as EC50, IC50, ED50, etc.) and measures of efficacy (such as tissue, cell or population response). A commonly used dose–response curve is the EC50 curve...
17 KB (1,788 words) - 21:35, 5 September 2024
inhibition at CB1 it displays a similar efficacy to that of Δ9-THC (EC50 = 11 nM vs. EC50 = 5.2 nM, respectively), but a lower maximum response (Emax = 28%...
7 KB (650 words) - 16:09, 21 October 2024
the CB1 receptors with an EC50 of 44.4nM for 9R-HHCP and 134nM for 9S-HHCP. Compared to Hexahydrocannabinol (HHC) with an EC50 of 101nM for 9R-HHC and 1...
5 KB (450 words) - 16:05, 21 October 2024
as a strong non-competitive selective NMDA receptor antagonist, with an EC50 of 20 μM; which might promote sedation in addition with the strong antihistaminergic...
32 KB (2,680 words) - 04:25, 26 October 2024
compared to D9-THC (1.6x). 9R-HHC has an EC50 of 3.4nM ± 1.5nM at CB1 and 6.2nM ± 2.1nM at CB2 while 9S-HHC has an EC50 of 57nM ± 19nM at CB1 and 55nM ± 10nM...
18 KB (1,869 words) - 18:04, 15 October 2024